TY  - CHAP
AU  - Shigeki Kato
AU  - Masahito  Kuramochi
AU  - Kenta Kobayashi
AU  - Ken-Ichi Inoue
AU  - Masahiko Takada
AU  - Kazuto Kobayashi
ED  - Ke Xu
Y1  - 2011-07-20
PY  - 2011
T1  - Highly Efficient Retrograde Gene Transfer for Genetic Treatment of Neurological Diseases
N2  - The development of technologies that allow targeting of specific cells has progressed substantially in recent years for several types of vectors, particularly viral vectors, which have been used in 70% of gene therapy clinical trials. Particular viruses have been selected as gene delivery vehicles because of their capacities to carry foreign genes and their ability to efficiently deliver these genes associated with efficient gene expression. This book is designed to present the most recent advances in viral gene therapy
BT  - Viral Gene Therapy
SP  - Ch. 17
UR  - https://doi.org/10.5772/21992
DO  - 10.5772/21992
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-23
ER  -